tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMNN Stock Latest News

Imunon, Inc. Earnings Call: Clinical Progress Amid Financial Challenges
Company AnnouncementsImunon, Inc. Earnings Call: Clinical Progress Amid Financial Challenges
2m ago
IMNN
Imunon reports Q1 EPS (28c), consensus (36c)
PremiumThe Fly
Imunon reports Q1 EPS (28c), consensus (36c)
14h ago
IMNN
Imunon sees cash runway into late 2Q25
PremiumThe Fly
Imunon sees cash runway into late 2Q25
14h ago
IMNN
IMNN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IMNN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
IMNN
Imunon announces first trial site initiated for Phase 3 OVATION 3 study
PremiumThe Fly
Imunon announces first trial site initiated for Phase 3 OVATION 3 study
5d ago
IMNN
Imunon announces data from Phase 1/2 OVATION 2 trial of IMNN-001
PremiumThe FlyImunon announces data from Phase 1/2 OVATION 2 trial of IMNN-001
7d ago
IMNN
Imunon announces IMNN-001 abstract accepted for oral presentation at 2025 ASCO
Premium
The Fly
Imunon announces IMNN-001 abstract accepted for oral presentation at 2025 ASCO
22d ago
IMNN
Imunon files to sell 10M shares of common stock, warrants
Premium
The Fly
Imunon files to sell 10M shares of common stock, warrants
1M ago
IMNN
Imunon Receives Buy Rating for Strategic Focus and Cost-Effective OVATION 3 Trial
PremiumRatings
Imunon Receives Buy Rating for Strategic Focus and Cost-Effective OVATION 3 Trial
2M ago
IMNN
Imunon finalizes Phase 3 study design with FDA for IMNN-001
PremiumThe Fly
Imunon finalizes Phase 3 study design with FDA for IMNN-001
2M ago
IMNN
Imunon’s Strategic Clinical Advancements and Promising Research Drive Buy Rating
PremiumRatings
Imunon’s Strategic Clinical Advancements and Promising Research Drive Buy Rating
2M ago
IMNN
IMUNON, Inc. Reports 2024 Financial Results and Advances Clinical Programs
PremiumCompany Announcements
IMUNON, Inc. Reports 2024 Financial Results and Advances Clinical Programs
2M ago
IMNN
Imunon, Inc. Earnings Call: Clinical Success Amid Financial Challenges
PremiumCompany AnnouncementsImunon, Inc. Earnings Call: Clinical Success Amid Financial Challenges
2M ago
IMNN
Imunon reports 2024 EPS ($1.62) vs. ($2.16) last year
Premium
The Fly
Imunon reports 2024 EPS ($1.62) vs. ($2.16) last year
2M ago
IMNN
Imunon announces new analyses of results from Phase 1 trial of IMNN-101
Premium
The Fly
Imunon announces new analyses of results from Phase 1 trial of IMNN-101
3M ago
IMNN
IMNN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IMNN Upcoming Earnings Report: What to Expect?
3M ago
IMNN
Imunon announces data from Phase 2 OVATION 2 Study of IMNN-001
PremiumThe Fly
Imunon announces data from Phase 2 OVATION 2 Study of IMNN-001
3M ago
IMNN
Imunon Appoints Dr. Douglas Faller as CMO
PremiumCompany Announcements
Imunon Appoints Dr. Douglas Faller as CMO
3M ago
8K
IMNN
Imunon appoints Faller as Chief Medical Officer
PremiumThe Fly
Imunon appoints Faller as Chief Medical Officer
3M ago
IMNN
Imunon announces positive outcome of Type C CMC meeting with FDA on IMNN-001
PremiumThe FlyImunon announces positive outcome of Type C CMC meeting with FDA on IMNN-001
5M ago
IMNN
Imunon announces additional data from results from Phase 2 OVATION 2 study
Premium
The Fly
Imunon announces additional data from results from Phase 2 OVATION 2 study
5M ago
IMNN
Imunon announces results from End-of-Phase 2 meeting with FDA for IMNN-001
Premium
The Fly
Imunon announces results from End-of-Phase 2 meeting with FDA for IMNN-001
6M ago
IMNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >